AU2020324628A1 - Composition for cartilage regeneration promotion - Google Patents

Composition for cartilage regeneration promotion Download PDF

Info

Publication number
AU2020324628A1
AU2020324628A1 AU2020324628A AU2020324628A AU2020324628A1 AU 2020324628 A1 AU2020324628 A1 AU 2020324628A1 AU 2020324628 A AU2020324628 A AU 2020324628A AU 2020324628 A AU2020324628 A AU 2020324628A AU 2020324628 A1 AU2020324628 A1 AU 2020324628A1
Authority
AU
Australia
Prior art keywords
composition
cartilage
cartilage regeneration
promoting
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020324628A
Other languages
English (en)
Inventor
Ayuta FUNAKI
Yuta OTSUKA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Holdings Ltd
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of AU2020324628A1 publication Critical patent/AU2020324628A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AU2020324628A 2019-08-02 2020-07-21 Composition for cartilage regeneration promotion Abandoned AU2020324628A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019143144 2019-08-02
JP2019-143144 2019-08-02
PCT/JP2020/028306 WO2021024801A1 (ja) 2019-08-02 2020-07-21 軟骨再生促進用組成物

Publications (1)

Publication Number Publication Date
AU2020324628A1 true AU2020324628A1 (en) 2022-03-10

Family

ID=74503458

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020324628A Abandoned AU2020324628A1 (en) 2019-08-02 2020-07-21 Composition for cartilage regeneration promotion

Country Status (9)

Country Link
EP (1) EP4008401A4 (https=)
JP (1) JP7457713B2 (https=)
KR (1) KR20220042403A (https=)
CN (1) CN114206330A (https=)
AU (1) AU2020324628A1 (https=)
CA (1) CA3147400A1 (https=)
PH (1) PH12022550260A1 (https=)
TW (1) TW202120078A (https=)
WO (1) WO2021024801A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7457353B2 (ja) * 2020-04-28 2024-03-28 学校法人北陸大学 軟骨細胞への分化促進剤、軟骨細胞の増殖促進剤および軟骨基質産生促進剤
US20240390407A1 (en) * 2021-09-17 2024-11-28 Hokuriku University Promoter for differentiation into cartilage cell, cartilage cell propagation promoter, and cartilage matrix production promoter
WO2025031857A1 (en) 2023-08-09 2025-02-13 Basf Se Fungicidal compositions comprising carboxamides
CN117736980B (zh) * 2024-02-20 2024-05-10 广东先康达生物科技有限公司 脂肪间充质干细胞转化成软骨细胞的诱导分化培养基及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0725761A (ja) * 1993-07-09 1995-01-27 Kureha Chem Ind Co Ltd 軟骨保護剤
JP4592249B2 (ja) * 2001-11-30 2010-12-01 江崎グリコ株式会社 リウマチの症状改善用飲食品および医薬
KR100437274B1 (ko) * 2003-10-15 2004-06-24 주식회사 케이엠에스아이 연골재생제로서 아피제닌을 함유하는 골관절염 치료 조성물
WO2014138372A1 (en) * 2013-03-06 2014-09-12 Primavera Biosciences, Inc. Composition and method for treating osteoarthritis
RU2521227C1 (ru) * 2013-03-28 2014-06-27 Общество С Ограниченной Ответственностью "Парафарм" Композиция для лечения и предупреждения остеоартрита, остеопороза и остеоартроза суставов
CA2913621A1 (en) * 2013-05-29 2014-12-04 Nestec S.A. Compositions for use in cartilage breakdown
EP3563855A1 (en) * 2013-10-14 2019-11-06 Société des Produits Nestlé S.A. Treatment or prevention of synovitis using anti-inflammatory phytonutrients
JP6742575B2 (ja) 2015-07-02 2020-08-19 株式会社東洋新薬 関節機能改善組成物
KR101794503B1 (ko) * 2016-03-24 2017-11-08 주식회사 티제이씨라이프 강글리오사이드 ｇｍ３를 함유하는 연골세포 분화 유도용 조성물 및 이의 이용
CN108938618B (zh) * 2018-06-25 2022-04-22 中国科学院动物研究所 延缓人间充质干细胞衰老的化合物及其应用

Also Published As

Publication number Publication date
PH12022550260A1 (en) 2022-11-21
CN114206330A (zh) 2022-03-18
CA3147400A1 (en) 2021-02-11
WO2021024801A1 (ja) 2021-02-11
EP4008401A1 (en) 2022-06-08
KR20220042403A (ko) 2022-04-05
JPWO2021024801A1 (https=) 2021-02-11
TW202120078A (zh) 2021-06-01
JP7457713B2 (ja) 2024-03-28
EP4008401A4 (en) 2023-05-03

Similar Documents

Publication Publication Date Title
AU2020324628A1 (en) Composition for cartilage regeneration promotion
Weaver et al. Soy isoflavones and bone health: the relationship is still unclear
US8778882B2 (en) Agent for strengthening calcium containing tissue and use thereof
ES2384452T3 (es) Composición alimentaria y métodos
CA2126513A1 (en) Chondroprotective agents
EP2084141A1 (en) Prevention and reversal of chemotherapy-induced peripheral neuropathy
WO2007042271A2 (en) Nutraceutical composition for the treatment of muscle wasting
RU2435580C2 (ru) Составы, обладающие антиканцерогенными свойствами
JP4390428B2 (ja) 含カルシウム組織強化剤
JP4450355B2 (ja) ウレアーゼ阻害剤、アンモニア臭抑制剤およびおむつかぶれ防止剤
Hulsey et al. An anorectic agent from adipose tissue of overfed rats: effects on feeding behavior
CN105558435A (zh) 一种用于防治鲢鱼出血病的饲料添加剂
HK40068648A (zh) 软骨再生促进用组合物
Castle Present status of the etiology of pernicious anemia
JP2001081034A (ja) 動物用抗原虫剤
JP7332489B2 (ja) ホスホジエステラーゼ３阻害用組成物及び血小板凝集抑制用組成物
JP2019147772A (ja) ヘプシジン発現抑制剤、並びに鉄欠乏性貧血改善及び／又は予防用飲食品
AU2003273444B2 (en) Use of Ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass
KR102531782B1 (ko) 루토나린을 포함하는 골질환 예방 또는 치료용 조성물
JP2005137217A (ja) 鳥類用飼料添加物、鳥類用肉質改善剤、鳥類用中性脂肪抑制剤及び鳥類用生産性向上剤、並びにこれらを含有する鳥類用飼料
Falchetti et al. Osteodietology
JP2005047849A (ja) 鳥類用抗菌組成物、鳥類用産卵向上添加剤、及び鳥類用飼料添加剤
WO2025234835A1 (ko) Dock5 억제제 및 bmp를 포함하는 조골세포 분화 촉진용 조성물 및 이의 용도
JP2012149000A (ja) 免疫賦活剤ならびにこれを含む食品および医薬組成物
KR20080016548A (ko) 육종 및 전립선암 치료용 영양제 조성물

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period